Vanguard Personalized Indexing Management, LLC Erytech Pharma S.A. Transaction History

Vanguard Personalized Indexing Management, LLC

  • $6.09 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$0.34 - $1.38 $10,393 - $42,183
-30,568 Reduced 55.74%
24,271 $23,000
Q4 2022

Feb 10, 2023
SELL
$0.33 - $0.68 $1,650 - $3,400
-5,000 Reduced 8.36%
54,839 $18,000
Q3 2022

Nov 14, 2022
SELL
$0.6 - $1.31 $21,257 - $46,411
-35,429 Reduced 37.19%
59,839 $33,000
Q2 2022

Aug 09, 2022
BUY
$1.03 - $1.8 $98,126 - $171,482
95,268 New
95,268 $107,000

About Erytech Pharma S.A.

ERYP Quotes by TradingView
  • Ticker ERYP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,018,600
  • Market Cap $16.8M
  • Description
  • ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...
More about ERYP
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email